Medical Innovation Exchange

Irlab's shares plummet 60% after Ipsen-partnered Parkinson's drug flunks phase 2 trial

https://www.fiercebiotech.com/biotech/irlabs-shares-plummet-60-after-ipsen-partnered-parkinsons-drug-flunks-phase-2-trial

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!